In the recent study, world health organization said, revamped drugs that can withstand in extreme heat and stay active for even 1000 days. This drug which has revolutionized the ability to keep new mothers alive.
Revamped is the known as the heat stable Carbetocin. It helps to prevent the fatal bleeding after the women give birth to the baby. This drug is given to millions of women worldwide at the time of giving birth. Existing drugs can help, but the problem of humid heat conditions in many countries restrict these existing drug working well.
In a study, it was found that each year 70000 women die due to severe bleeding after giving birth. These so-called postpartum increases the risk of their babies dying in the first month of life.
To come out with this problem, world health organization suggests an injection of oxytocin be offered to all the women who are giving birth vaginally.
World health organization recommends that the medicine should be kept between 2 – 8 degrees. But along with that expert says that is it not possible in some countries due to little access to refrigeration. Or sometimes not likely due to the unreliable power supply.
In the trial, 30000 women in 10 countries have randomly selected an injection of heat stable Carbetocin or oxytocin is given immediately after they gave birth. Researchers found that both the drugs are equally good at preventing the flow of the blood after giving birth.
Dr. Metin Gulmezoglu of WHO Statement
Experts say this heat-stable Carbetocin to be offered to all the women giving birth. It is very useful in the area where the oxytocin is substandard.
Dr. Metin Gulmezoglu who is expert of WHO said, Excellent news for the millions of women who give birth in parts of the world without access to reliable refrigeration
It is the best way to save the lives of mothers in lower income countries where most death occurs due to the bleeding after giving birth.
The drug is available for other uses. Now the regulators will look at whether they use this drug for broader use.
WHO expert say they hope it will be available in some countries as early next year.